119 related articles for article (PubMed ID: 24989813)
21. Integrase-defective lentiviral-vector-based vaccine: a new vector for induction of T cell immunity.
Negri DR; Michelini Z; Bona R; Blasi M; Filati P; Leone P; Rossi A; Franco M; Cara A
Expert Opin Biol Ther; 2011 Jun; 11(6):739-50. PubMed ID: 21434847
[TBL] [Abstract][Full Text] [Related]
22. Integrase-defective lentiviral vectors: progress and applications.
Banasik MB; McCray PB
Gene Ther; 2010 Feb; 17(2):150-7. PubMed ID: 19847206
[TBL] [Abstract][Full Text] [Related]
23. Integrase-defective lentiviral vectors as a delivery platform for targeted modification of adenosine deaminase locus.
Joglekar AV; Hollis RP; Kuftinec G; Senadheera S; Chan R; Kohn DB
Mol Ther; 2013 Sep; 21(9):1705-17. PubMed ID: 23857176
[TBL] [Abstract][Full Text] [Related]
24. Integration-deficient lentiviral vectors: a slow coming of age.
Wanisch K; Yáñez-Muñoz RJ
Mol Ther; 2009 Aug; 17(8):1316-32. PubMed ID: 19491821
[TBL] [Abstract][Full Text] [Related]
25. Integrase defective, nonintegrating lentiviral vectors.
Michelini Z; Negri D; Cara A
Methods Mol Biol; 2010; 614():101-10. PubMed ID: 20225038
[TBL] [Abstract][Full Text] [Related]
26. Efficient gene expression from integration-deficient lentiviral vectors in the spinal cord.
Peluffo H; Foster E; Ahmed SG; Lago N; Hutson TH; Moon L; Yip P; Wanisch K; Caraballo-Miralles V; Olmos G; Lladó J; McMahon SB; Yáñez-Muñoz RJ
Gene Ther; 2013 Jun; 20(6):645-57. PubMed ID: 23076378
[TBL] [Abstract][Full Text] [Related]
27. Non-integrating lentiviral vectors.
Sarkis C; Philippe S; Mallet J; Serguera C
Curr Gene Ther; 2008 Dec; 8(6):430-7. PubMed ID: 19075626
[TBL] [Abstract][Full Text] [Related]
28. Placenta-specific gene activation and inactivation using integrase-defective lentiviral vectors with the Cre/LoxP system.
Morioka Y; Isotani A; Oshima RG; Okabe M; Ikawa M
Genesis; 2009 Dec; 47(12):793-8. PubMed ID: 19830817
[TBL] [Abstract][Full Text] [Related]
29. Integrase-Defective Lentiviral Vectors for Delivery of Monoclonal Antibodies against Influenza.
Michelini Z; Minkoff JM; Yang J; Negri D; Cara A; Hanson BJ; Salvatore M
Viruses; 2020 Dec; 12(12):. PubMed ID: 33348840
[TBL] [Abstract][Full Text] [Related]
30. Initial Characterization of Integrase-Defective Lentiviral Vectors for Pancreatic Cancer Gene Therapy.
Hanoun N; Gayral M; Pointreau A; Buscail L; Cordelier P
Hum Gene Ther; 2016 Feb; 27(2):184-92. PubMed ID: 26731312
[TBL] [Abstract][Full Text] [Related]
31. Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery.
Lombardo A; Genovese P; Beausejour CM; Colleoni S; Lee YL; Kim KA; Ando D; Urnov FD; Galli C; Gregory PD; Holmes MC; Naldini L
Nat Biotechnol; 2007 Nov; 25(11):1298-306. PubMed ID: 17965707
[TBL] [Abstract][Full Text] [Related]
32. Assessment of Integration-defective HIV-1 and EIAV Vectors In Vitro and In Vivo.
Ellis S; Fong-Wong L; Iqball S; Thoree V; Mitrophanous KA; Binley K
Mol Ther Nucleic Acids; 2012 Dec; 1(12):e60. PubMed ID: 23232328
[TBL] [Abstract][Full Text] [Related]
33. Safety and efficiency modifications of SIV-based integrase-defective lentiviral vectors for immunization.
Bona R; Michelini Z; Mazzei C; Gallinaro A; Canitano A; Borghi M; Vescio MF; Di Virgilio A; Pirillo MF; Klotman ME; Negri D; Cara A
Mol Ther Methods Clin Dev; 2021 Dec; 23():263-275. PubMed ID: 34729374
[TBL] [Abstract][Full Text] [Related]
34. Hybrid lentivirus-transposon vectors with a random integration profile in human cells.
Staunstrup NH; Moldt B; Mátés L; Villesen P; Jakobsen M; Ivics Z; Izsvák Z; Mikkelsen JG
Mol Ther; 2009 Jul; 17(7):1205-14. PubMed ID: 19240688
[TBL] [Abstract][Full Text] [Related]
35. High-efficiency transduction of spinal cord motor neurons by intrauterine delivery of integration-deficient lentiviral vectors.
Ahmed SG; Waddington SN; Boza-Morán MG; Yáñez-Muñoz RJ
J Control Release; 2018 Mar; 273():99-107. PubMed ID: 29289570
[TBL] [Abstract][Full Text] [Related]
36. Successful therapeutic vaccination with integrase defective lentiviral vector expressing nononcogenic human papillomavirus E7 protein.
Grasso F; Negri DR; Mochi S; Rossi A; Cesolini A; Giovannelli A; Chiantore MV; Leone P; Giorgi C; Cara A
Int J Cancer; 2013 Jan; 132(2):335-44. PubMed ID: 22700466
[TBL] [Abstract][Full Text] [Related]
37. Lentiviral vector-mediated overexpression of mutant ataxin-7 recapitulates SCA7 pathology and promotes accumulation of the FUS/TLS and MBNL1 RNA-binding proteins.
Alves S; Marais T; Biferi MG; Furling D; Marinello M; El Hachimi K; Cartier N; Ruberg M; Stevanin G; Brice A; Barkats M; Sittler A
Mol Neurodegener; 2016 Jul; 11(1):58. PubMed ID: 27465358
[TBL] [Abstract][Full Text] [Related]
38. Intrastriatal Delivery of Integration-Deficient Lentiviral Vectors in a Rat Model of Parkinson's Disease.
Lu-Nguyen NB; Broadstock M; Yáñez-Muñoz RJ
Methods Mol Biol; 2016; 1448():175-84. PubMed ID: 27317181
[TBL] [Abstract][Full Text] [Related]
39. Unbiased detection of off-target cleavage by CRISPR-Cas9 and TALENs using integrase-defective lentiviral vectors.
Wang X; Wang Y; Wu X; Wang J; Wang Y; Qiu Z; Chang T; Huang H; Lin RJ; Yee JK
Nat Biotechnol; 2015 Feb; 33(2):175-8. PubMed ID: 25599175
[TBL] [Abstract][Full Text] [Related]
40. Integration-defective lentiviral vector mediates efficient gene editing through homology-directed repair in human embryonic stem cells.
Wang Y; Wang Y; Chang T; Huang H; Yee JK
Nucleic Acids Res; 2017 Mar; 45(5):e29. PubMed ID: 27899664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
